3SBio 주식 주식분석 | 주식가격 | 뉴스 | 1530.HK | KYG8875G1029 | A14T7Q

날짜	3SBio 주식 가격
	0 undefined
	6.02 undefined
	6.01 undefined
	5.74 undefined
	5.68 undefined
	5.70 undefined
	5.59 undefined
	5.78 undefined
	5.71 undefined
	5.84 undefined
	5.97 undefined
	5.91 undefined
	5.95 undefined
	5.83 undefined
	5.60 undefined
	5.39 undefined
	5.42 undefined
	5.36 undefined
	5.36 undefined

날짜	3SBio 매출	3SBio EBIT	3SBio 이익
2029e	13.32 조. undefined	0 undefined	0 undefined
2028e	12.38 조. undefined	0 undefined	0 undefined
2027e	10.82 조. undefined	2.59 조. undefined	1.38 조. undefined
2026e	10.82 조. undefined	3.22 조. undefined	2.37 조. undefined
2025e	9.88 조. undefined	2.96 조. undefined	2.19 조. undefined
2024e	9.05 조. undefined	2.74 조. undefined	1.96 조. undefined
2023	7.82 조. undefined	2.45 조. undefined	1.55 조. undefined
2022	6.87 조. undefined	2 조. undefined	1.92 조. undefined
2021	6.38 조. undefined	1.76 조. undefined	1.65 조. undefined
2020	5.59 조. undefined	1.43 조. undefined	835.79 백만 undefined
2019	5.32 조. undefined	1.22 조. undefined	973.72 백만 undefined
2018	4.58 조. undefined	1.3 조. undefined	1.28 조. undefined
2017	3.73 조. undefined	1.17 조. undefined	935.39 백만 undefined
2016	2.8 조. undefined	918.81 백만 undefined	712.56 백만 undefined
2015	1.67 조. undefined	464.35 백만 undefined	526.28 백만 undefined
2014	1.13 조. undefined	356.11 백만 undefined	291.73 백만 undefined
2013	875.4 백만 undefined	193.8 백만 undefined	95.9 백만 undefined
2012	669.9 백만 undefined	128.8 백만 undefined	102.4 백만 undefined
2011	541.6 백만 undefined	121.6 백만 undefined	108.6 백만 undefined
2010	418.6 백만 undefined	88.1 백만 undefined	81.3 백만 undefined
2009	316.9 백만 undefined	85 백만 undefined	83.4 백만 undefined
2008	243.2 백만 undefined	48.2 백만 undefined	39.5 백만 undefined
2007	180.2 백만 undefined	49.6 백만 undefined	81.5 백만 undefined
2006	127.8 백만 undefined	39.7 백만 undefined	30.5 백만 undefined
2005	102 백만 undefined	23.9 백만 undefined	16.1 백만 undefined
2004	77.2 백만 undefined	12.6 백만 undefined	6.6 백만 undefined

	매출	EBIT	이익
2004	77.2 백만 CNY	12.6 백만 CNY	6.6 백만 CNY
2005	102 백만 CNY	23.9 백만 CNY	16.1 백만 CNY
2006	127.8 백만 CNY	39.7 백만 CNY	30.5 백만 CNY
2007	180.2 백만 CNY	49.6 백만 CNY	81.5 백만 CNY
2008	243.2 백만 CNY	48.2 백만 CNY	39.5 백만 CNY
2009	316.9 백만 CNY	85 백만 CNY	83.4 백만 CNY
2010	418.6 백만 CNY	88.1 백만 CNY	81.3 백만 CNY
2011	541.6 백만 CNY	121.6 백만 CNY	108.6 백만 CNY
2012	669.9 백만 CNY	128.8 백만 CNY	102.4 백만 CNY
2013	875.4 백만 CNY	193.8 백만 CNY	95.9 백만 CNY
2014	1.13 조. CNY	356.11 백만 CNY	291.73 백만 CNY
2015	1.67 조. CNY	464.35 백만 CNY	526.28 백만 CNY
2016	2.8 조. CNY	918.81 백만 CNY	712.56 백만 CNY
2017	3.73 조. CNY	1.17 조. CNY	935.39 백만 CNY
2018	4.58 조. CNY	1.3 조. CNY	1.28 조. CNY
2019	5.32 조. CNY	1.22 조. CNY	973.72 백만 CNY
2020	5.59 조. CNY	1.43 조. CNY	835.79 백만 CNY
2021	6.38 조. CNY	1.76 조. CNY	1.65 조. CNY
2022	6.87 조. CNY	2 조. CNY	1.92 조. CNY
2023	7.82 조. CNY	2.45 조. CNY	1.55 조. CNY
2024e	9.05 조. CNY	2.74 조. CNY	1.96 조. CNY
2025e	9.88 조. CNY	2.96 조. CNY	2.19 조. CNY
2026e	10.82 조. CNY	3.22 조. CNY	2.37 조. CNY
2027e	10.82 조. CNY	2.59 조. CNY	1.38 조. CNY
2028e	12.38 조. CNY	0 CNY	0 CNY
2029e	13.32 조. CNY	0 CNY	0 CNY

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.02	0.03	0.03	0.81	0.73	0.73	0.58	0.77	0.88	0.53	0.16	1.9	1.04	3.1	1.86	2.56	4.36	4.77	7.01	5.99
0.06	0.05	0.04	0.06	0.05	0.06	0.08	0.11	0.12	0.14	0.22	0.41	0.68	1.19	1.35	0.93	0.86	1.29	1.22	1.01
4	6	12	11	32	35	90	66	84	98	191.41	273.75	227.45	568.59	794.34	533.89	674.66	577.48	92.56	400.65
9	6	9	7	8	15	22	28	35	50	100.4	134.39	262.44	376.53	384.61	528.47	619.51	690.52	712.74	777.54
0	0	0.01	0.01	0	0.02	0.02	0.02	0.01	0.11	0.26	0.04	0.03	0.04	0.05	0.05	0.16	0.47	0.71	1.01
0.1	0.1	0.09	0.89	0.83	0.85	0.79	0.99	1.12	0.93	0.94	2.76	2.24	5.28	4.44	4.6	6.68	7.79	9.75	9.19
0.05	0.04	0.04	0.05	0.08	0.17	0.2	0.2	0.23	0.25	0.38	0.46	1.8	1.76	1.79	2.32	2.98	3.83	4.5	5.15
0	0	0	0.02	0.04	0.02	0.14	0.05	0.05	0	0.24	1.73	0.14	0.08	0.7	1.28	1.65	1.32	1.38	3.13
0	0	0	0	0	0	3	3	2	1	0.35	0	79.52	35.37	28.76	6.56	2.2	0	0	0
0	0.01	0.01	0.01	0.01	0.01	0.05	0.07	0.06	0.04	0.41	0.5	2.29	2.25	2.3	2.17	1.9	1.85	1.58	1.55
0	0	0	0	0	0	0	0	0	0	0.23	0.56	4.13	3.92	4.09	4.15	3.92	3.84	4.14	4.2
3	2	1	2	1	2	0	0	24	44	116.97	615.9	367.38	422.76	492.01	292.93	544.91	579.31	657.76	391.96
0.05	0.05	0.05	0.08	0.13	0.2	0.39	0.32	0.36	0.34	1.36	3.87	8.8	8.48	9.4	10.21	11	11.42	12.26	14.43
0.15	0.15	0.14	0.97	0.95	1.05	1.19	1.31	1.48	1.27	2.31	6.63	11.04	13.75	13.84	14.81	17.68	19.21	22.01	23.63

63	63	0	0	0	0	0	0	0	0	0	0.15	0.16	0.16	0.16	0.16	0.16	0.16	0.15	0.15
0.02	0.02	0.08	0.92	0.91	0.92	0.95	0.97	0.99	0.64	0.52	4.55	4.55	4.57	4.59	4.55	4.65	4.15	3.69	3.52
-0.05	-0.04	-0.01	0.07	0.11	0.2	0.28	0.39	0.53	0.59	0.58	1.1	1.82	2.75	3.89	4.87	5.7	7.87	9.33	10.82
1	2	0	-48	-102	-101	-111	-122	-159	-161	-168.67	-33.78	158.82	81.06	174.6	202.33	142.15	104.1	175.88	79.46
0	0	0	0	0	1	22	-5	5	7	6.53	1.7	0.06	-4.39	0.16	1.05	197.09	98.38	-35.5	-151.57
0.03	0.04	0.07	0.94	0.92	1.01	1.14	1.23	1.37	1.07	0.93	5.62	6.52	7.4	8.66	9.63	10.69	12.23	13.16	14.27
1	1	2	2	2	3	5	6	4	7	25.64	34.44	58.79	274.57	112.92	149.76	203.29	230.41	249.52	212.06
11	11	16	22	25	27	32	42	0	0	0	0	334.9	459.06	618.05	636.45	496.48	643.4	742.78	994
1	1	2	1	2	8	11	15	81	83	608.82	333.17	231.47	374.72	354.25	336.09	383.99	385.43	426.11	400.21
71	91	19	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0.62	0.41	0.52	1.09	0.57	0.49	0.37	0.16	0.43	2.12
0.08	0.1	0.04	0.03	0.03	0.04	0.05	0.06	0.09	0.09	1.25	0.77	1.14	2.2	1.66	1.61	1.45	1.42	1.84	3.73
0.03	0	0.03	0	0	0	0	0	0	0	0	0	2.54	3.32	2.72	2.32	2.55	2.47	4.09	2.72
0	0	0	0	0	0	0	0	0	65	73.62	81.79	294.4	280.27	270.76	268.08	272.24	264.47	279.87	250.55
6	5	4	4	4	3	2	2	13	32	37.34	140.57	293.76	328.58	281.64	248.18	314.74	402.2	428.54	416.76
0.04	0.01	0.03	0	0	0	0	0	0.01	0.1	0.11	0.22	3.13	3.93	3.28	2.84	3.13	3.13	4.8	3.38
0.12	0.11	0.07	0.03	0.03	0.04	0.05	0.07	0.1	0.19	1.36	0.99	4.27	6.12	4.93	4.45	4.58	4.55	6.65	7.11
0.15	0.15	0.14	0.97	0.95	1.05	1.19	1.3	1.47	1.26	2.3	6.62	10.79	13.52	13.59	14.08	15.27	16.78	19.81	21.38

2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0.01	0.02	0.03	0.08	0.04	0.08	0.08	0.11	0.13	0.21	0.36	0.59	0.85	1.1	1.5	1.22	0.98	1.87	2.27
7	8	8	5	4	6	8	15	22	30	40	33	77	161	243	313	333	360	329	366
1,000	0	1,000	1,000	0	1,000	-1,000	1,000	0	0	0	0	0	0	0	0	0	0	0	0
-23	-6	0	-1	-18	-12	-8	-63	-16	-35	-120	-107	-124	-118	-376	-506	-10	-555	-619	-276
-1	-1	-1	1	1	25	7	24	22	19	89	100	-85	111	104	-152	341	560	0	-183
5	6	5	4	0	0	0	0	0	0	0	28	25	131	125	66	38	196	6	45
0	0	0	2	5	8	12	20	21	35	49	133	65	122	130	263	355	254	286	346
-0.02	0.01	0.02	0.04	0.07	0.06	0.09	0.06	0.14	0.14	0.22	0.39	0.46	1	1.07	1.15	1.89	1.34	1.58	2.18
-2	0	-9	-2	-17	-42	-95	-82	-52	-54	-50	-25	-97	-466	-259	-462	-486	-981	-1,145	-973
-24	2	-9	17	-36	-368	-266	-165	-52	-201	481	-289	-3,248	-4,381	-643	-405	-1,133	-1,869	-1,286	-3,721
-21	3	0	19	-19	-326	-170	-83	0	-147	531	-263	-3,150	-3,914	-383	56	-647	-888	-140	-2,748
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.03	0	-0.01	-0.05	-0.04	0	0	0	0	0	0	0.59	-0.28	2.52	1.49	-1.19	-0.52	0.03	-0.11	1.63
0	0	0	0	0.92	-0.01	0	0.01	0	0	0	0	4.13	0	0	-0.04	-0.03	-0.01	-0.41	-0.48
0.03	0	-0.01	-0.05	0.8	-0.01	0	0.01	0.02	0	-0.59	-0.25	3.87	2.71	1.32	-1.39	-0.45	1.55	-0.48	0.71
0	0	0	-0.01	-0.08	0	0	0	0.01	0	-0.59	-0.84	0.02	0.19	-0.17	-0.01	0.11	1.53	0.04	-0.03
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-150	-16	0	0	-417
-0.01	0.01	0.01	0	0.79	-0.37	-0.18	-0.11	0.09	-0.06	0.11	-0.16	1.19	-0.62	1.72	-0.61	0.29	1.01	-0.22	-0.72
-18.9	6.3	15.6	34.3	51.5	18.2	-7.2	-24	84.3	90.3	167.3	360.66	357.75	538.29	814.86	687.86	1,401.13	363.09	432.57	1,206.54
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

3SBio 브루토마진	3SBio 이익 마진	3SBio EBIT-마진	3SBio 이익 마진
2029e	84.98 %	0 %	0 %
2028e	84.98 %	0 %	0 %
2027e	84.98 %	23.94 %	12.74 %
2026e	84.98 %	29.74 %	21.94 %
2025e	84.98 %	29.91 %	22.16 %
2024e	84.98 %	30.32 %	21.66 %
2023	84.98 %	31.37 %	19.82 %
2022	82.61 %	29.13 %	27.9 %
2021	82.67 %	27.61 %	25.87 %
2020	80.98 %	25.55 %	14.96 %
2019	82.6 %	22.85 %	18.31 %
2018	80.86 %	28.44 %	27.86 %
2017	81.89 %	31.34 %	25.05 %
2016	85.62 %	32.85 %	25.47 %
2015	85.54 %	27.75 %	31.45 %
2014	92.26 %	31.49 %	25.8 %
2013	90.5 %	22.14 %	10.95 %
2012	89.48 %	19.23 %	15.29 %
2011	89.27 %	22.45 %	20.05 %
2010	90.04 %	21.05 %	19.42 %
2009	92.05 %	26.82 %	26.32 %
2008	91.08 %	19.82 %	16.24 %
2007	90.34 %	27.52 %	45.23 %
2006	90.92 %	31.06 %	23.87 %
2005	84.8 %	23.43 %	15.78 %
2004	80.57 %	16.32 %	8.55 %

	브루토마진	EBIT-마진	이익 마진
2004	80.57 %	16.32 %	8.55 %
2005	84.8 %	23.43 %	15.78 %
2006	90.92 %	31.06 %	23.87 %
2007	90.34 %	27.52 %	45.23 %
2008	91.08 %	19.82 %	16.24 %
2009	92.05 %	26.82 %	26.32 %
2010	90.04 %	21.05 %	19.42 %
2011	89.27 %	22.45 %	20.05 %
2012	89.48 %	19.23 %	15.29 %
2013	90.5 %	22.14 %	10.95 %
2014	92.26 %	31.49 %	25.8 %
2015	85.54 %	27.75 %	31.45 %
2016	85.62 %	32.85 %	25.47 %
2017	81.89 %	31.34 %	25.05 %
2018	80.86 %	28.44 %	27.86 %
2019	82.6 %	22.85 %	18.31 %
2020	80.98 %	25.55 %	14.96 %
2021	82.67 %	27.61 %	25.87 %
2022	82.61 %	29.13 %	27.9 %
2023	84.98 %	31.37 %	19.82 %
2024e	84.98 %	30.32 %	21.66 %
2025e	84.98 %	29.91 %	22.16 %
2026e	84.98 %	29.74 %	21.94 %
2027e	84.98 %	23.94 %	12.74 %
2028e	84.98 %	0 %	0 %
2029e	84.98 %	0 %	0 %

날짜	3SBio 주당 매출	3SBio EBIT 당 주식	3SBio 주당 이익
2029e	5.56 undefined	0 undefined	0 undefined
2028e	5.17 undefined	0 undefined	0 undefined
2027e	4.52 undefined	0 undefined	0.58 undefined
2026e	4.52 undefined	0 undefined	0.99 undefined
2025e	4.13 undefined	0 undefined	0.91 undefined
2024e	3.78 undefined	0 undefined	0.82 undefined
2023	3.2 undefined	1 undefined	0.63 undefined
2022	2.59 undefined	0.76 undefined	0.72 undefined
2021	2.3 undefined	0.64 undefined	0.6 undefined
2020	2.03 undefined	0.52 undefined	0.3 undefined
2019	2.1 undefined	0.48 undefined	0.38 undefined
2018	1.66 undefined	0.47 undefined	0.46 undefined
2017	1.41 undefined	0.44 undefined	0.35 undefined
2016	1.09 undefined	0.36 undefined	0.28 undefined
2015	0.73 undefined	0.2 undefined	0.23 undefined
2014	0.58 undefined	0.18 undefined	0.15 undefined
2013	0.45 undefined	0.1 undefined	0.05 undefined
2012	4.21 undefined	0.81 undefined	0.64 undefined
2011	3.45 undefined	0.77 undefined	0.69 undefined
2010	2.72 undefined	0.57 undefined	0.53 undefined
2009	2.1 undefined	0.56 undefined	0.55 undefined
2008	1.6 undefined	0.32 undefined	0.26 undefined
2007	1.23 undefined	0.34 undefined	0.56 undefined
2006	1.28 undefined	0.4 undefined	0.31 undefined
2005	1.02 undefined	0.24 undefined	0.16 undefined
2004	0.77 undefined	0.13 undefined	0.07 undefined

	주당 매출	EBIT 당 주식	주당 이익
2004	0.77 CNY	0.13 CNY	0.07 CNY
2005	1.02 CNY	0.24 CNY	0.16 CNY
2006	1.28 CNY	0.4 CNY	0.31 CNY
2007	1.23 CNY	0.34 CNY	0.56 CNY
2008	1.6 CNY	0.32 CNY	0.26 CNY
2009	2.1 CNY	0.56 CNY	0.55 CNY
2010	2.72 CNY	0.57 CNY	0.53 CNY
2011	3.45 CNY	0.77 CNY	0.69 CNY
2012	4.21 CNY	0.81 CNY	0.64 CNY
2013	0.45 CNY	0.1 CNY	0.05 CNY
2014	0.58 CNY	0.18 CNY	0.15 CNY
2015	0.73 CNY	0.2 CNY	0.23 CNY
2016	1.09 CNY	0.36 CNY	0.28 CNY
2017	1.41 CNY	0.44 CNY	0.35 CNY
2018	1.66 CNY	0.47 CNY	0.46 CNY
2019	2.1 CNY	0.48 CNY	0.38 CNY
2020	2.03 CNY	0.52 CNY	0.3 CNY
2021	2.3 CNY	0.64 CNY	0.6 CNY
2022	2.59 CNY	0.76 CNY	0.72 CNY
2023	3.2 CNY	1 CNY	0.63 CNY
2024e	3.78 CNY	0 CNY	0.82 CNY
2025e	4.13 CNY	0 CNY	0.91 CNY
2026e	4.52 CNY	0 CNY	0.99 CNY
2027e	4.52 CNY	0 CNY	0.58 CNY
2028e	5.17 CNY	0 CNY	0 CNY
2029e	5.56 CNY	0 CNY	0 CNY

	주식 수량
2004	100 백만 Aktien
2005	100 백만 Aktien
2006	100 백만 Aktien
2007	146.7 백만 Aktien
2008	151.7 백만 Aktien
2009	151 백만 Aktien
2010	154.1 백만 Aktien
2011	157.1 백만 Aktien
2012	159 백만 Aktien
2013	1.94 조. Aktien
2014	1.94 조. Aktien
2015	2.3 조. Aktien
2016	2.56 조. Aktien
2017	2.65 조. Aktien
2018	2.75 조. Aktien
2019	2.54 조. Aktien
2020	2.75 조. Aktien
2021	2.77 조. Aktien
2022	2.65 조. Aktien
2023	2.44 조. Aktien
2024e	2.44 조. Aktien
2025e	2.44 조. Aktien
2026e	2.44 조. Aktien
2027e	2.44 조. Aktien
2028e	2.44 조. Aktien
2029e	2.44 조. Aktien

날짜	3SBio 배당금
2029e	0.11 undefined
2028e	0.11 undefined
2027e	0.11 undefined
2026e	0.11 undefined
2025e	0.11 undefined
2024e	0.11 undefined
2023	0.1 undefined
2022	0.2 undefined
2018	0.07 undefined

	배당금	배당금 (추정)
2004	0 CNY	0 CNY
2005	0 CNY	0 CNY
2006	0 CNY	0 CNY
2007	0 CNY	0 CNY
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0 CNY	0 CNY
2011	0 CNY	0 CNY
2012	0 CNY	0 CNY
2013	0 CNY	0 CNY
2014	0 CNY	0 CNY
2015	0 CNY	0 CNY
2016	0 CNY	0 CNY
2017	0 CNY	0 CNY
2018	0.07 CNY	0 CNY
2019	0 CNY	0 CNY
2020	0 CNY	0 CNY
2021	0 CNY	0 CNY
2022	0.2 CNY	0 CNY
2023	0.1 CNY	0 CNY
2024e	0 CNY	0.11 CNY
2025e	0 CNY	0.11 CNY
2026e	0 CNY	0.11 CNY
2027e	0 CNY	0.11 CNY
2028e	0 CNY	0.11 CNY
2029e	0 CNY	0.11 CNY

날짜	3SBio 배당률
2029e	25.22 %
2028e	25.34 %
2027e	25.29 %
2026e	25.02 %
2025e	25.71 %
2024e	25.15 %
2023	24.2 %
2022	27.78 %
2021	23.48 %
2020	21.33 %
2019	21.33 %
2018	14.89 %
2017	21.33 %
2016	21.33 %
2015	21.33 %
2014	21.33 %
2013	21.33 %
2012	21.33 %
2011	21.33 %
2010	21.33 %
2009	21.33 %
2008	21.33 %
2007	21.33 %
2006	21.33 %
2005	21.33 %
2004	21.33 %

	배당률
2004	21.33 %
2005	21.33 %
2006	21.33 %
2007	21.33 %
2008	21.33 %
2009	21.33 %
2010	21.33 %
2011	21.33 %
2012	21.33 %
2013	21.33 %
2014	21.33 %
2015	21.33 %
2016	21.33 %
2017	21.33 %
2018	14.89 %
2019	21.33 %
2020	21.33 %
2021	23.48 %
2022	27.78 %
2023	24.2 %
2024e	25.15 %
2025e	25.71 %
2026e	25.02 %
2027e	25.29 %
2028e	25.34 %
2029e	25.22 %

%-지분	이름	주식	변경
19.90234 %	Century Sunshine Ltd.	476,774,553	0
3.83130 %	BlackRock Institutional Trust Company, N.A.	91,781,500	15,726,000
2.35720 %	Lou (Jing)	56,468,448	5,000,000
2.29382 %	The Vanguard Group, Inc.	54,949,996	-11,500
1.48075 %	Dimensional Fund Advisors, L.P.	35,472,500	0
1.38906 %	HSBC JinTrust Fund Management Co., Ltd.	33,276,000	23,915,000
1.36370 %	Medical Recovery Ltd.	32,668,480	-2,322,000
1.34404 %	Huang (Bin)	32,197,350	0
1.30192 %	Bosera Asset Management Co., Ltd.	31,188,500	-102,500
1.17676 %	China Southern Asset Management Co. Ltd.	28,190,000	26,967,000
1.10794 %	GF Fund Management Co., Ltd.	26,541,500	802,000
1.01791 %	Su (Dongmei)	24,384,630	0
0.93024 %	BlackRock Financial Management, Inc.	22,284,500	9,275,500
0.79094 %	Bankinter Gesti¿n de Activos, SGIIC S.A.	18,947,500	-7,576,500
0.68819 %	Universal Vintage Ltd.	16,486,000	-75,000
0.61155 %	Norges Bank Investment Management (NBIM)	14,650,138	-1,209,734
0.60334 %	Harvest Fund Management Co., Ltd.	14,453,500	-3,110,500
0.53844 %	Zhang (Jiaoe)	12,898,639	12,898,639
0.52681 %	Fullgoal Fund Management Co., Ltd.	12,620,000	6,437,500
0.45939 %	BlackRock Investment Management (UK) Ltd.	11,004,955	3,625,669
0.44591 %	Ninety One UK Limited	10,682,000	238,500
0.44108 %	BlackRock (Netherlands) B.V.	10,566,436	5,106,528
0.43215 %	China Asset Management Co., Ltd.	10,352,500	1,480,000
0.41637 %	E Fund Management Co. Ltd.	9,974,500	6,712,000
0.38271 %	APG Asset Management N.V.	9,167,970	323,804
0.24785 %	BlackRock Advisors (UK) Limited	5,937,500	103,000
0.23635 %	China Merchants Fund Management Co. Ltd.	5,662,000	4,782,000
0.22826 %	Bessemer Trust Company, N.A. (US)	5,468,216	0
0.22196 %	California State Teachers Retirement System	5,317,249	-5,231,000
0.22099 %	State Street Global Advisors (UK) Ltd.	5,294,066	282,000
0.19108 %	BlackRock Asset Management Ireland Limited	4,577,500	-17,705,500
0.17155 %	Nordea Investment Management AB (Denmark)	4,109,500	154,000
0.17036 %	Z¿rcher Kantonalbank (Asset Management)	4,081,000	0
0.16119 %	ICBC Credit Suisse Asset Management Co. Ltd.	3,861,500	1,408,500
0.15700 %	HuaAn Fund Management Co., Ltd.	3,761,000	3,726,000
0.13823 %	California Public Employees' Retirement System	3,311,500	797,000
0.13287 %	Dimensional Fund Advisors, Ltd.	3,183,000	63,500
0.12433 %	JP Morgan Asset Management	2,978,500	0
0.12173 %	SEI Investments Management Corporation	2,916,077	0
0.12003 %	American Century Investment Management, Inc.	2,875,500	0
0.11928 %	INVESCO Great Wall Fund Management Co. Ltd.	2,857,500	-3,853,500
0.11469 %	MFS Investment Management	2,747,500	0
0.11432 %	Jupiter Asset Management Ltd.	2,738,500	-3,319,500
0.11102 %	PGGM Vermogensbeheer B.V.	2,659,443	1,190,063
0.11040 %	Polunin Capital Partners Limited	2,644,784	-525,000
0.10768 %	Goldman Sachs Asset Management International	2,579,500	2,579,500
0.10573 %	China Asset Management (Hong Kong) Limited	2,532,800	13,500
0.10549 %	State Street Global Advisors (US)	2,526,977	-12,000
0.10068 %	Charles Schwab Investment Management, Inc.	2,411,885	0
0.09019 %	First Seafront Fund Management Co., Ltd.	2,160,500	2,071,000
0.08837 %	Penghua Fund Management Co., Ltd.	2,117,000	-27,000
0.08764 %	Vident Investment Advisory, LLC	2,099,500	0
0.08349 %	Huisheng Fund Management Co., Ltd.	2,000,000	2,000,000
0.08342 %	China Universal Asset Management Co., Ltd.	1,998,500	1,613,500
0.08075 %	Mellon Investments Corporation	1,934,500	-49,500
0.07798 %	HSBC Global Asset Management (UK) Limited	1,868,143	583,481
0.07010 %	SEB Investment Management AB	1,679,256	905,461
0.06664 %	Allianz Global Investors GmbH	1,596,305	-27,000
0.05896 %	PensionDanmark A/S	1,412,472	1,412,472
0.05855 %	Taikang Asset Management Co., Ltd.	1,402,500	1,364,500
0.05684 %	First Trust Advisors L.P.	1,361,553	13,000
0.05401 %	Goldman Sachs Asset Management, L.P.	1,293,855	-76,960
0.05287 %	Nuveen LLC	1,266,500	0
0.04866 %	Swedbank Robur Fonder AB	1,165,600	0
0.04723 %	Yinhua Fund Management Co., Ltd.	1,131,500	-32,000
0.04556 %	Numeric Investors LLC	1,091,368	478,941
0.04195 %	AXA Investment Managers UK Ltd.	1,005,000	626,000
0.04095 %	BlackRock Fund Advisors	981,000	981,000
0.03847 %	Guotai Asset Management Co., Ltd.	921,619	448,268
0.03730 %	State Street Global Advisors (Japan) Co., Ltd.	893,620	108,500
0.03673 %	Geode Capital Management, L.L.C.	879,973	-7,027
0.03152 %	Manulife Fund Management Co., Ltd.	755,000	755,000
0.03139 %	Parametric Portfolio Associates LLC	752,000	0
0.02935 %	HFT Investment Management Co., Ltd.	703,082	98,500
0.02887 %	Grantham Mayo Van Otterloo & Co LLC	691,500	64,000
0.02665 %	Florida State Board of Administration	638,400	415,900
0.02638 %	Storebrand Kapitalforvaltning AS	632,000	-49,500
0.02534 %	Fidelity Management & Research Company LLC	607,000	607,000
0.02507 %	Legal & General Investment Management Ltd.	600,500	0
0.02482 %	BMO Asset Management Inc.	594,562	0
0.02480 %	British Columbia Investment Management Corp.	594,193	55,660
0.02434 %	State Street Global Advisors Ireland Limited	582,968	-23,000
0.02252 %	Ping An Fund Management Company Limited	539,500	85,500
0.02246 %	KEPLER-FONDS Kapitalanlagegesellschaft m.b.H.	538,000	-118,500
0.02177 %	Franklin Advisers, Inc.	521,500	87,500
0.02177 %	BlackRock Asset Management North Asia Limited	521,500	214,500
0.02077 %	Neuberger Berman, LLC	497,592	0
0.02077 %	Robeco Institutional Asset Management B.V.	497,592	0
0.02045 %	Bellevue Asset Management AG	490,000	173,000
0.01706 %	DFA Australia Ltd.	408,700	-377
0.01659 %	CPIC Fund Management Co., Ltd.	397,500	397,500
0.01626 %	Bank of Communications Schroder Fund Management Co., Ltd.	389,500	389,500
0.01550 %	Degroof Petercam Asset Management	371,414	-89,000
0.01386 %	Oaktree Capital Management, L.P.	332,000	0
0.01369 %	PGIM Quantitative Solutions LLC	327,955	0
0.01252 %	Handelsbanken Kapitalf¿rvaltning AB	300,000	0
0.00998 %	Vanguard Investments Australia Ltd.	239,163	0
0.00966 %	Vanguard Global Advisers LLC	231,500	0
0.00918 %	Topsperity Fund Management Co., Ltd.	220,000	220,000
0.00893 %	Mirae Asset Global Investments (USA) LLC	213,900	1,600

What values and corporate philosophy does 3SBio represent?

3SBio Inc represents a commitment to innovation, integrity, and excellence in the biopharmaceutical industry. The company values putting patients first and developing high-quality therapeutic solutions. With a focus on research and development, 3SBio Inc is dedicated to discovering, developing, and commercializing innovative biopharmaceutical products. The company's corporate philosophy centers around offering effective and affordable treatments to improve patients' lives. By staying true to their core values, 3SBio Inc aims to make a positive impact on healthcare and contribute to the well-being of individuals worldwide.

In which countries and regions is 3SBio primarily present?

3SBio Inc is primarily present in China and the United States.

What significant milestones has the company 3SBio achieved?

3SBio Inc has achieved several significant milestones. The company successfully completed its initial public offering (IPO) on the Hong Kong Stock Exchange in 2015, marking a major milestone in its history. Furthermore, 3SBio Inc has seen remarkable growth and success in the biopharmaceutical industry, particularly in the development and commercialization of innovative medicines. They have obtained regulatory approvals for various products, expanded their product portfolio, and established strategic partnerships to enhance their market presence. The company's dedication to research and development has also resulted in numerous scientific achievements and breakthroughs. Overall, 3SBio Inc has demonstrated consistent progress and remains a leading player in the biopharmaceutical sector.

What is the history and background of the company 3SBio?

3SBio Inc is a leading biotechnology company specializing in the research, development, and manufacturing of innovative biopharmaceutical products. Founded in 1993, the company has a rich history in the biotech industry. With its headquarters in China, 3SBio Inc has expanded globally and gained recognition for its expertise in therapeutic areas including nephrology, oncology, and immunology. The company is committed to improving patient outcomes through the development of high-quality, life-saving medications. 3SBio Inc has established itself as a trusted name in the biopharmaceutical sector, delivering innovative solutions to address unmet medical needs and improve the quality of life for patients worldwide.

Who are the main competitors of 3SBio in the market?

The main competitors of 3SBio Inc in the market include companies such as Johnson & Johnson, Pfizer Inc, Novartis International AG, Amgen Inc, and Roche Holding AG.

In which industries is 3SBio primarily active?

3SBio Inc is primarily active in the biotechnology and pharmaceutical industries.

What is the business model of 3SBio?

3SBio Inc operates as a leading biotechnology company. The business model of 3SBio Inc revolves around the research, development, manufacturing, and commercialization of biopharmaceutical products. The company focuses on developing innovative therapies to address unmet medical needs, particularly in the fields of oncology, nephrology, and autoimmune diseases. By leveraging their expertise in biologics and in-house manufacturing capabilities, 3SBio Inc aims to deliver high-quality and affordable medicines to patients worldwide. With a commitment to advancing healthcare, 3SBio Inc continues to invest in R&D efforts and strategic partnerships, aiming to improve patient outcomes and enhance their market presence.

3SBio 2025의 P/E 비율은 얼마입니까?

3SBio에 대한 현재 주가 수익 비율을 계산할 수 없습니다.

3SBio 2025의 KUV는 얼마입니까?

3SBio에 대한 현재 KUV는 계산할 수 없습니다.

3SBio의 AlleAktien 품질 점수는 얼마인가요?

3SBio에 대한 AlleAktien 품질 점수는 8/10입니다.

3SBio 2025의 매출은 얼마인가요?

예상되는 3SBio 매출은 9.88 조. CNY입니다.

3SBio 2025의 이익은 얼마인가요?

예상되는 3SBio 이익은 2.19 조. CNY입니다.

3SBio은 무엇을 하나요?

The Chinese company 3SBio Inc is a leading company in the biopharmaceutical industry, specializing in the development, manufacturing, and marketing of biological drugs. 3SBio focuses on the areas of oncology, immunology, nephrology, and infectious diseases. The main products of 3SBio include biosimilars of innovative drugs such as rituximab, enoxaparin, adalimumab, darbepoetin alfa, pegaspargase, and etanercept. Biosimilars are biologically manufactured drugs that have similar active ingredients as original biologics and thus provide a more cost-effective alternative. 3SBio has the largest market share for biosimilars in China and continually expands its portfolio. In addition to biosimilars, 3SBio also offers innovative biological drugs. One example is Tpiao, a recombinant human thrombopoietin receptor agonist. It is used to treat thrombocytopenia in patients with hepatitis B or hepatitis C infections. Another important area for 3SBio is nephrology. The company has various products in its portfolio that are used to treat kidney diseases. These include, for example, the erythropoiesis-stimulating agent (ESA) ferumoxytol, which is used to treat iron deficiency anemia in chronic kidney disease, as well as binodenoson, an adenosine receptor agonist used for diagnostic imaging of kidney diseases. The business model of 3SBio Inc is based on the acquisition of promising technologies, its own research and development work, and the manufacturing and marketing of biological drugs. The company works closely with regulatory authorities and health organizations to achieve fast market approval for its products. An important aspect is also international distribution. 3SBio strategically enters growth markets in Asia, especially in China, and expands into other parts of the world. Through partnerships with other companies and the acquisition of firms in the biopharmaceutical industry, 3SBio continuously expands its value chain and its portfolio. Overall, 3SBio pursues a diversified business model based on the utilization of synergies in the areas of research, development, manufacturing, and marketing of biological drugs. By utilizing biosimilars and innovative active ingredients, the company has achieved high competitiveness and is on a path of expansion.

3SBio 배당금은 얼마입니까?

3SBio은(는) 연간 번의 배당을 통해 0.2 CNY의 배당금을 지급합니다.

3SBio이 얼마나 자주 배당을 지급하나요?

3SBio의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

3SBio ISIN이 무엇입니까?

3SBio의 ISIN은 KYG8875G1029입니다.

3SBio WKN은 무엇인가요?

3SBio의 WKN은 A14T7Q입니다.

3SBio 티커는 무엇인가요?

3SBio의 티커는 1530.HK입니다.

3SBio이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 3SBio은(는) 0.1 CNY 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 3SBio은(는) 0.11 CNY의 배당금을 지급할 것으로 예상됩니다.

3SBio의 배당 수익률은 얼마입니까?

3SBio의 현재 배당 수익률은 입니다.

3SBio의 배당금은 언제 지급되나요?

3SBio은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

3SBio의 배당금은 얼마나 안전한가요?

3SBio은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

3SBio의 배당금은 얼마입니까?

향후 12개월 동안 0.11 CNY의 배당금이 예상됩니다. 이는 배당수익률 1.85 %에 해당합니다.

3SBio이(가) 속해 있는 섹터는 어디인가요?

3SBio은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von 3SBio kaufen, um die vorherige Dividende zu erhalten?

3SBio의 마지막 배당금을 0.25 CNY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

3SBio의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

3SBio의 2024년도 배당금은 얼마였습니까?

2024년에 3SBio는 0.1 CNY를 배당금으로 지급했습니다.

3SBio는 어떤 화폐로 배당금을 지급하나요?

3SBio의 배당금은 CNY에 지급됩니다.

Scope 1 - 직접 방출	728,600
스코프 2 - 구매한 에너지로부터의 간접적인 배출	206,807
Scope 3 - 가치 창출 체인 내의 간접 배출	23,567,680
총 CO₂ 배출량	935,407
CO₂ 감소 전략
석탄 에너지
원자력
동물 실험
펠츠 & 레더
살충제
팜 오일
담배
유전자 변형 생물체
기후 개념
지속 가능한 임업
재활용 규정
환경 친화적인 포장
위험물질
연료 소비량과 효율성
물 사용량 및 효율성

여성 직원 비율
관리 직위에서의 여성 비율
아시아 직원 비율
아시아 경영진 비율
히스패닉/라티노 직원 비율
히스패닉/라티노 관리 부문 지분
흑인 직원 비율
블랙 매니지먼트 지분
흰색 종업원의 비율
화이트 매니지먼트 지분
성인 콘텐츠
알코올
무기
총기
도박
군사 계약
인권 개념
개인정보 보호 정책
작업 및 건강 보호
카톨릭

환경 보고
이해관계자 참여
콜백 정책
카르텔법

증권거래소	3SBio 티커
뒤셀도르프	83B.DU
프랑크푸르트	83B.F
HKSE	1530.HK
뮌헨	83B.MU
PNK	TRSBF

3SBio 티커	3SBio FIGI
83B:GM	BBG009CK4GD8
83B:GB	BBG009CK4GF6
83B:TH	BBG009CVMW94
1530EUR:XG	BBG00CTTKM98
1530EUR:XO	BBG00CTTKMB5
1530:HK	BBG009BKGLS9
83B:GR	BBG009CK4G75
83B:GF	BBG009CK4G84
83B:GD	BBG009CK4G93
83B:GS	BBG009CK4GC9
1530:H1	BBG00B623T70
83B:QT	BBG00CTTGG23
1530EUR:EO	BBG00CTTKLZ1
1530EUR:XH	BBG00CTTKM25
1530EUR:XF	BBG00CTTKM43
1530EUR:XE	BBG00CTTKM61
1530EUR:XJ	BBG00CTTKM70
1530EUR:XL	BBG00CTTKM89
1530EUR:XS	BBG00CTTKMG0
1530EUR:XA	BBG00CTTKMH9
1530EUR:E1	BBG00CTTKMJ7
1530EUR:XT	BBG00CTTKMK5
1530EUR:XW	BBG00CTTKML4
1530EUR:XU	BBG00CTTKMM3
1530EUR:XV	BBG00CTTKMN2
1530EUR:EU	BBG00CTTKMQ9
1530:H2	BBG00F135N75
1530EUR:XX	BBG00JN8HFD9
1530HKD:X2	BBG00JPVMFC1
1530HKD:XB	BBG00JPVMFD0
1530HKD:XH	BBG00JPVMFG7
1530HKD:XF	BBG00JPVMFJ4
1530HKD:XE	BBG00JPVMFL1
1530HKD:XJ	BBG00JPVMFM0
1530HKD:XL	BBG00JPVMFN9
1530HKD:XG	BBG00JPVMFP7
1530HKD:XO	BBG00JPVMFQ6
1530HKD:XS	BBG00JPVMFV0
1530HKD:XA	BBG00JPVMFW9
1530HKD:E1	BBG00JPVMFX8
1530HKD:XT	BBG00JPVMFY7
1530HKD:XW	BBG00JPVMFZ6
1530HKD:XU	BBG00JPVMG02
1530HKD:XV	BBG00JPVMG11
1530HKD:XM	BBG00JPVMG20
1530HKD:XQ	BBG00JPVMG48
1530HKD:XX	BBG00JPVMG57
1530HKD:XZ	BBG00JPVMG66
1530HKD:EU	BBG00JPVMG93
1530N:PO	BBG00JRF8MX2
1530N:L3	BBG00JRFC993
1530N:B3	BBG00JRFF160
TRSBF:US	BBG00L5DRY23
TRSBF:PQ	BBG00L5DRYL2
TRSBF:UV	BBG00L5DRYM1
1530N:L1	BBG00Y7B1225
83B:LA	BBG018H9DRT8
83B:LU	BBG018J31SL8
83B:GZ	BBG01K0TCGL8

한 눈에 저평가된 주식을 인식하세요

3SBio 주식 주식과 주식 분석 3SBio ariva, 3SBio onvista, 3SBio finanzen.net, 3SBio aktienfinder, 3SBio marketscreener, 3SBio marketwatch, 3SBio bloomberg, 3SBio handelsblatt, 3SBio wiwo, 3SBio forum

가격

가격

티커1530.HK

ISINKYG8875G1029

WKNA14T7Q

3SBio 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

3SBio 주가 이력

3SBio 주식 매출, EBIT, 이익 KYG8875G1029 · A14T7Q

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

3SBio 매출, 이익 및 EBIT 역사

3SBio 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

3SBio 주식 마진 KYG8875G1029 · A14T7Q

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

3SBio 마진 역사

3SBio 주식 매출, EBIT, 주당 순이익 KYG8875G1029 · A14T7Q

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

3SBio 매출, 이익 및 EBIT 주당 역사

3SBio 주식 및 주식 분석

한눈에 과소평가된 주식을 인식하세요.

3SBio Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

3SBio 역사적인 P/E, EBIT 및 P/S에 따른 평가

한눈에 과소평가된 주식을 인식하세요.

3SBio 주식 수량 KYG8875G1029 · A14T7Q

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

3SBio 주식 배당금 KYG8875G1029 · A14T7Q

배당금

배당금에 대한 개요

해석 및 사용

투자 전략

3SBio 배당금 내역

3SBio 주식 배당률 KYG8875G1029 · A14T7Q

배당비율

연간 배당비율이란 무엇인가요?

데이터 해석 방법

3SBio 주식
주식과 주식 분석 3SBio ariva, 3SBio onvista, 3SBio finanzen.net, 3SBio aktienfinder, 3SBio marketscreener, 3SBio marketwatch, 3SBio bloomberg, 3SBio handelsblatt, 3SBio wiwo, 3SBio forum

티커
1530.HK

ISIN
KYG8875G1029

WKN
A14T7Q